Skip to main content
OpenTrials
Completed

NCT Number: NCT05496439

Study of the Prognosis of Patients With Heart Failure With Preserved Ejection Fraction

Study of the prognosis of patients with heart failure with preserved ejection fraction

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

The First Affiliated Hospital of Chongqing Medical University

Chongqing, China

About this study

Obesity is an independent risk factor for heart failure with preserved ejection fraction (HFpEF), however, the impact of visceral fat area (VFA) in patients with HFpEF is unclear. According to established process of patients' selection, a total of 172 patients whose mean age was 72 years were included in this study, and the median follow-up duration was 395.5 days(interquartile range: 207.5 to 535.5 days). All patients were divided into two groups based on the best cut-off value of VFA, and the primary outcome of this study was all-cause death in patients with HFpEF. The aim of this study was to clarify whether VFA has prognostic value in patients with HFpEF by Kaplan-Meier analysis and cox analysis.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult aged >=18years old;
  • Diagnosed with HFpEF.Diagnostic criteria including:

1)left ventricular ejection fraction ≥50%; 2)with the symptoms and/or signs of heart failure; 3)BNP≥35 pg/mL and/or NTproBNP≥125 pg/mL; 4)at least one additional criterion: relevant structural heart disease(LVH and/or LAE) or diastolic dysfunction

Exclusion criteria

  • Age <18 years old;
  • LVEF less than 45% at any time;
  • cancer diagnosis.

Treatment and study plan

Primary outcomes

  1. death

    Time frame: The median follow-up time of 395.5 days(interquartile range: 207.5 to 535.5 days)

    all-cause death

Sponsors and collaborators

Lead sponsor

Chongqing Medical University

Other

Registry information

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
Aug 11, 2022
Registry last updated
Aug 11, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.